The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants

ADVERTISEMENT

TheHeart.Org

By Professionals for Professionals

Not one for flash and tinsel, theheart.org is thick with information on the front page. The interface seems based on that used by the New York Times, complete with a “most popular” widget that displays the most visited articles on the site.

Owned by WebMD, which is in turn owned by News Corporation, the site is bereft of fluff and advertisements, instead presenting columns and columns of relevant content. The news and information is as professionally presented as one would expect from an arm of such a worldwide conglomerate, and is aimed squarely at knowledgeable experts.

Membership

Membership is expected, the free registration option is prominently displayed when one first visits the site, and most of its features and content can only be accessed once this is done. Until then, only headlines and tidbits are displayed.

Registration comes in two types: limited access for 30 days, which gives access to their news articles and requires only an email address; and full access, which requires slightly more information and opens up the entire site, including the search and comment functions. Given the quality of the content and the fact that registration is free, it is well worth it for anyone interested.

Focus

The focus of theheart.org is the various diseases and disorders of the heart, and also how to prevent them. By design, the site exchanges breadth for depth–aside from a single section called “Brain/Kidney/Peripheral,” there is no information present that is unrelated to the topic of heart disease. That topic, however, is covered in careful detail. The site would be of little use to a student of human physiology, as the basic anatomy and functioning of the heart is barely mentioned, let alone outlined. It is similarly not designed to lure in the general public, or even patients of heart disease. With titles such as “Antiplatelets in PCI: Doses and Choices” and “The Atrial Septal Pouch–A New Source of Thrombus?”, it is clearly meant to be perused by cardiologists and other healthcare professionals.

Cardiology Excellence

In its chosen area of discussion, however, theheart.org excels. There is nothing sloppy or amateur about this site or the quality of its articles. In fact, it is so professional as to be exclusive, as even the user comments on its posts are often in-depth discussions of medical considerations that a layman would be hard-pressed to decipher.

A doctor, however, could find a wealth of information, news and analysis on the subject of heart functioning and disorders, keeping up-to-date on new discoveries, treatments, medications such as cangrelor and: http://www.theheart.org/article/1024935.do dabigatran, as well as what is happening within the cardiologist community.

Assessment

In summary, there is no shortage of content on the topic of the heart: news articles, blog posts, editorials, and even video and radio programs. A professional in the field of heart health should not fail to become a regular visitor to theheart.org, while a more casual reader would probably find their needs best met elsewhere.

Conclusion

And so, your thoughts and comments on this ME-P sponsor are appreciated. Give em’ a click and tell us what you think! Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites too. Then, be sure to subscribe to the ME-P. It is fast, free and secure.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Filed under: "Doctors Only", Sponsors | Tagged: cangrelor, cardiology, dabigatran etexilate, News Corporation, theHeart.org, WebMD | Leave a comment »